Joha Park

Joha Park is a Senior Computational Scientist at Intellia Therapeutics, Inc., where responsibilities include developing platforms for CRISPR-Cas9 off-target prediction, addressing genetic variations for gene therapy, creating scalable computational workflows, and providing support for IND and BLA filing. Prior experience includes serving as a Postdoctoral Associate/Fellow at the Massachusetts Institute of Technology, focusing on microscopy 3D imaging data analysis and hydrogel-based tissue clearing, and as a Postdoctoral Researcher at the Institute for Basic Science, conducting research on mRNA poly(A)-tail length regulation. Joha Park holds a PhD in Bioinformatics and RNA Biology from Seoul National University, as well as a Bachelor's Degree in Biological Sciences from the same institution and has completed education at Hansung Science High School.